Biodexa Pharmaceuticals Bolsa (NASDAQ: BDRX)

Últimas noticias sobre Biodexa Pharmaceuticals (NASDAQ:BDRX) Bolsa

Biodexa Pharmaceuticals

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Mercados

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATNF

BDRX

DECK

HNRG

IMMX

INEO

INTU

LITM

LTBR

MLGO

MNSO

OKLO

ROST

SGBX

SOBR

VTAK

Intuit sorprende al mercado con ingresos y BPA mejores de lo esperado. Revisa los mayores ganadores y perdedores del premercado.

Las acciones de Intuit (INTU) cotizan un 8% más alto; Aquí están 20 acciones que se mueven en el premercado

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals PLC

BOMBARDIER 6.25% PFD A by Bombardier Inc.

Bombardier Inc

Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google DeepMind CEO Demis Hassabis has offered a more cautious outlook on the arrival of <a href="https://www.benzinga.com/news/legal/25/04/44975360/geoffrey-hinton-ex-openai-insiders-and-top-ai-experts-sound-alarm-on-openais-restructuring-warn-it-could-strip-public-of-oversight-betray-agi-mission">artificial general intelligence</a> (AGI) than the tech giant's co-founder, Sergey Brin. 
What Happened: In a <a href="https://www.nytimes.com/2025/05/23/podcasts/google-ai-demis-hassabis-hard-fork.html">conversation</a> on the Hard Fork podcast by the New York Times this week, the interviewer pointed out that Brin thinks AGI will come before 2030, while Hassabis says just after 2030.
This raised an intriguing question: given that both individuals likely have access to similar data, roadmaps, and insights into the state of AI development, what accounts for their differing forecasts on AGI's arrival? What is one seeing that the other is not?
In response, Hassabis said that he is sticking to a timeline he's maintained since DeepMind's founding in 2010.
"We thought it was roughly a 20-year mission, and amazingly, we're on track," Hassabis said. "It's somewhere around there, I would think."
See Also:&nbsp;<a href="https://www.benzinga.com/tech/25/05/45486639/sundar-pichai-reveals-google-parent-once-super-intensely-debated-about-buying-netflix-in-a-world-of-butterfly-effects" target="_blank" rel="noreferrer noopener">Sundar Pichai Reveals Google-Parent Once Super Intensely Debated About Buying Netflix: ‘In A World Of Butterfly Effects…'</a>
Earlier, Brin jokingly accused Hassabis of "sandbagging"—intentionally downplaying timelines to later overdeliver. However, during the interview, Hassabis stood by his reasoning, pointing to the complexity of defining AGI itself.
"I have quite a high bar," he said. "It should be able to do all of the things that the human brain can do, even theoretically. And so that's a that's a higher bar than, say, what the typical individual human could do, which is obviously very economically important."
When asked whether AGI would emerge through steady improvements or sudden breakthroughs, Hassabis said both are likely necessary. "We push unbelievably hard on the scaling," he said, while also investing in "blue sky" research like AlphaEvolve.
Why It's Important: Last year, Anthropic CEO Dario Amodei predicted that <a href="https://www.benzinga.com/tech/24/11/41928832/anthropic-ceo-says-ai-similar-to-human-intelligence-could-be-around-the-corner-well-get-there-by-2026-or-2027">AGI could become a reality</a> as early as 2026 or 2027, though he cautioned that unforeseen external factors might delay its development.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
OpenAI CEO Sam Altman has previously said that <a href="https://www.benzinga.com/media/25/01/42867568/openai-ceo-sam-altman-predicts-agi-will-arrive-during-the-trump-presidency-says-chips-act-not-effective-enough">AGI could arrive during</a> Donald Trump's presidency.
In 2022, Ark Invest CEO Cathie Wood also suggested that AGI could become a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/05/27339602/cathie-wood-has-cure-for-sagging-gdp-growth-sees-this-technology-accelerating-annua">major driver of economic growth</a>.
The definition of AGI itself remains fluid. As <a href="https://www.tomsguide.com/ai/chatgpt/sam-altman-claims-agi-is-coming-in-2025-and-machines-will-be-able-to-think-like-humans-when-it-happens">noted</a> by Tom's Guide, while some define AGI as human-level competence across all domains, others focus on its capacity to learn, adapt, and perform tasks in ways that mirror human cognition, requiring the system to go beyond its initial training data and generate truly autonomous output.
Price Action: Alphabet Inc.'s Class A shares fell 1.40% on Friday, while Class C shares declined 1.39%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Benzinga Edge Stock Rankings assigns Alphabet a growth score of 88.68%. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Click here to see how it compares to other companies</a>.
<figure class="wp-block-image aligncenter size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23213419/Screenshot-2025-05-24-at-7.03.26%E2%80%AFAM.png" alt="" class="wp-image-926680" /></a></figure>
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/04/45090992/mark-zuckerberg-warns-of-serious-disadvantage-as-chinas-data-center-blitz-could-let-deepseek-leapfrog-us-ai-labs" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Warns Of ‘Serious Disadvantage&#8217; As China&#8217;s Data-Center Blitz Could Let DeepSeek Leapfrog US AI Labs</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: JHVEPhoto / Shutterstock.com

Tech

Media

GOOG

GOOGL

Why Google's Demis Hassabis Disagrees With Co-Founder Sergey Brin On When AGI Will Arrive: 'I Have Quite A High Bar'

Most people call "The Dave Ramsey" Show <a href="https://www.benzinga.com/money/are-you-rich">looking for advice</a>. Some call to vent. And then there's the rare few—like Russ from Salem—who call in ready to challenge the man himself.
Featured in an episode of the show titled "<a href="https://youtu.be/g_K-8ekMbmY?si=RKH6e1xJXXNfOzfB">Unforgettable Calls, Volume 2</a>," Russ came in with a different angle. As an insurance broker with 35 years of experience, he wasn't calling for help—he was there to play devil's advocate on one of Ramsey's favorite punching bags: whole life insurance.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Right out of the gate, Russ pushed back on Ramsey's widely known view that term life insurance is always the best option.
"You have said… term insurance is the best and the only kind of product people should buy in all instances," Russ said, offering a more "situational" perspective.
Ramsey didn't flinch. "There are basic principles of mathematics and basic principles of personal finance that are always the same," he said. "I would tell you there is never a time that <a href="https://www.benzinga.com/25/05/45297103/a-dave-ramsey-fan-explains-how-they-feel-free-after-cutting-every-credit-card-im-tired-of-managing-payments-every-month">you would use a credit card</a>… and I think the same thing's true of whole life."
What followed was a back-and-forth that quickly turned from debate to sparring match—especially when Russ argued that if whole life policies are "written appropriately," the policyholder's beneficiaries can receive not only the face value but the cash value, too.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
Ramsey shut that down quickly.
"That just doesn't happen, dude," he said. "You and I know that. That is not how the industry is set up."
Russ held his ground, claiming he'd written policies that did pay out both. Ramsey wasn't buying it—and then delivered the line that had listeners reaching for the replay button.
"It is the payday lender of the middle class," he said. "It's a horrid product when you pay 20 times more for the same amount of coverage to build up a cash value that you never receive."
Russ tried to defend the product's use in corporate buy-sell agreements, noting that many major companies and financial professionals use whole life policies to <a href="https://www.benzinga.com/personal-finance/25/05/45395648/billionaire-charlie-munger-said-he-dropped-insurance-after-getting-rich-all-intelligent-people-self-insure-if-they-can-afford-it">fund business arrangements</a>.
See Also: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
Ramsey wasn't impressed.
"Because people like you sell that crap to them," he snapped. "That's exactly why they do it."
The call wrapped with both men firmly in their corners—Ramsey warning against what he called "garbage R Us" financial products, and Russ insisting that when structured properly, whole life insurance still has value.
But for longtime Ramsey listeners, it was classic Dave: direct, confrontational, and unshaken by industry pushback.
And for anyone still weighing whether whole life insurance is worth it? Well, Ramsey's take is clear. If you're paying 20 times more for the same coverage, expect him to call it what he believes it is: a bad deal dressed up in a sales pitch.
Read Next:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a> </li>
</ul>
Image: Shutterstock

Personal Finance

'It's the Payday Lender of the Middle Class' — Dave Ramsey Rips Whole Life Insurance in Heated Call With 35-Year Broker: 'It Just Doesn't Happen, Dude'

WHLRD

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

FRGT

WHLR

WHLRL

PLRZ

APVO

WHLRP

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 10 years by 7.73% on an annualized basis producing an average annual return of 18.27%. Currently, Parker Hannifin has a market capitalization of $84.34 billion. 
Buying $100 In PH: If an investor had bought $100 of PH stock 10 years ago, it would be worth $530.98 today based on a price of $654.96 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748043011_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Parker Hannifin 10 Years Ago Would Be Worth Today

TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) has outperformed the market over the past 10 years by 3.77% on an annualized basis producing an average annual return of 14.31%. Currently, TJX Companies has a market capitalization of $141.44 billion. 
Buying $1000 In TJX: If an investor had bought $1000 of TJX stock 10 years ago, it would be worth $3,780.45 today based on a price of $125.82 for TJX at the time of writing.
<h3>TJX Companies's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748042112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In TJX Companies 10 Years Ago Would Be Worth Today

The number of famous Wall Street analysts and economic experts warning about recession has surged dramatically in recent weeks. Much of this concern stems from weakening consumer sentiment and a slowing economy. The US GDP <a href="https://www.cnbc.com/2025/04/30/gdp-q1-2025-.html">fell </a>0.3% year over year in the March quarter, marking the first quarterly decline since 2022.&nbsp;
Robert Kiyosaki, investor and author of the best-selling book "Rich Dad Poor Dad," said last month that the US may be heading toward a "greater depression" as the economy continues to worsen. Kiyosaki <a href="https://x.com/theRealKiyosaki/status/1913366747010531408">wrote</a> on X that he had predicted this "chaos" and he is "sad" that the financial crisis he predicted is "here."
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
"In 2025 credit card debt is at all-time highs," Kiyosaki said. "US debt is at all-time highs. Unemployment is rising.&nbsp; 401 k's are losing. Pensions are being stolen."
However, Kiyosaki pointed to a silver lining, telling his followers there's an opportunity to emerge from the crisis as a "very rich" person.
<h2 class="wp-block-heading">‘It's Not Too Late'</h2>
Kiyosaki urged his followers to pile into bitcoin, gold and silver if they want to get rich despite the incoming "financial disaster."
"For those who take action today, when the crash crashes, those who invest in just one Bitcoin, or some gold, or silver," he said. "You may come through this crisis a very rich person.&nbsp; It's not too late, if you take action. But if you wait, it may be too late, after the giant crash."
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
Kiyosaki said he was reiterating his call to invest in precious metals and bitcoin, even as some on X criticized him for repeating the same advice.
The author, who has long <a href="https://www.richdad.com/rich-dad-scams-get-out-of-debt">questioned</a> the belief that debt should be avoided, warned that those who delay or are fearful would be the "biggest losers."
"If a poor person bought a few ounces of gold or silver, or 1/2 of a Bitcoin, I predict they may become the new rich….once this Depression is over," according to Kiyosaki. "I strongly believe, by 2035, that one Bitcoin will be over $1 million dollars. Gold will be $30k and silver $3,000 a coin."
See Also: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
Spot gold has hit multiple <a href="https://www.reuters.com/business/finance/golds-record-run-gains-further-traction-market-conquers-3500oz-2025-04-22/">record highs</a> this year as investors flocked to the precious metal amid inflation and tariff-related headwinds. Gold is up 22% so far this year. JP Morgan <a href="https://www.reuters.com/business/finance/golds-record-run-gains-further-traction-market-conquers-3500oz-2025-04-22/">expects</a> gold prices to cross $4,000 per ounce by the second quarter of next year.
Earlier this month, Kiyosaki <a href="https://x.com/theRealKiyosaki/status/1920823604834427220">claimed</a> on X that poor and middle-class Americans were flocking to Costco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) stores to buy gold bars.
"Costco cannot keep enough gold bars and coins in stock," he said. "It means the poor and middle class have finally got my rich dad's message and are now saving real money by converting fake money…. for real gold."
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Image: Shutterstock

COST

Robert Kiyosaki Says US Heading for 'Greater Depression' But You Can Become 'Very Rich Person' In This Crisis If You Do This

Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) has outperformed the market over the past 10 years by 2.18% on an annualized basis producing an average annual return of 12.73%. Currently, Allison Transmission has a market capitalization of $8.64 billion. 
Buying $100 In ALSN: If an investor had bought $100 of ALSN stock 10 years ago, it would be worth $327.70 today based on a price of $101.35 for ALSN at the time of writing.
<h3>Allison Transmission's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748041212_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALSN

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) has outperformed the market over the past 15 years by 4.25% on an annualized basis producing an average annual return of 16.13%. Currently, Eaton Corp has a market capitalization of $126.85 billion. 
Buying $1000 In ETN: If an investor had bought $1000 of ETN stock 15 years ago, it would be worth $9,179.70 today based on a price of $320.98 for ETN at the time of writing.
<h3>Eaton Corp's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748040312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

After decades of pinching pennies and <a href="https://www.benzinga.com/personal-finance/25/05/45483330/are-you-rich-or-just-upper-middle-class-heres-the-net-worth-and-income-it-takes-to-be-considered-wealthy">watching that retirement account climb</a>, it can be a strange kind of shock to switch gears and actually spend it.
That's where Kevin, a 65-year-old electrician from Georgia, finds himself—14 months away from retirement with a <a href="https://www.benzinga.com/money/smartasset">$1.7 million nest egg</a>, no debt outside a mortgage, and enough future income to live on $96,000 a year without even touching the principal. And yet, the idea of watching those savings go down? It's driving him nuts.
"I've been a saver all my life," Kevin told Dave Ramsey on an <a href="https://youtu.be/5TNIgmVM6ZQ?si=EoFarcaNXSmShJT_">episode of "The Ramsey Show</a>." "It's just… there's something in my head about seeing those savings going the other direction."
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
He's not worried about running out of money. In fact, Kevin said he doesn't think he and his wife will ever need to dip into their investments unless there's a major medical issue. But still—after a lifetime of saving, spending feels wrong.
Ramsey got it. "You spent 66 years building up one muscle—your saving muscle," he said. "What I'm trying to do there is I'm trying to stretch your spending muscle a little bit."
To help loosen that grip, Ramsey gave Kevin a financial assignment: "Put your toe in the water and make yourself, by setting a written goal—you and your wife—that you're going to spend X on fun."
Specifically? "I want you to plan to spend $8,000 on a cruise this year."
Kevin responded, "Wow… I know that's a lot."
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a>
Ramsey reminded him, "Yeah, I know that's a lot, but you got 1.7 million, dude. I didn't even take the sweat off your interest."
And the spending "fun" didn't stop at tropical getaways. Kevin admitted he's had his eye on a SawStop table saw that runs over $3,000. Ramsey approved. "Perfect. You didn't tell me 300,000—I would've smacked you silly."
The advice was simple: spend with purpose, not recklessly—but spend. Practice enjoying what you've earned.
Ramsey even challenged Kevin to stretch his generosity muscle while he was at it: "Find somebody to give some money to. Generosity goes with spending. They're kissing cousins."
It's a lesson that hits home for plenty of late-career savers. You spend decades saying no, trimming the extras, pushing just a little further—and then one day, you're told it's time to say yes. That shift doesn't come easy. But as Kevin's story shows, learning to enjoy what you've earned isn't reckless. It's <a href="https://www.benzinga.com/money/are-you-rich">part of the payoff</a>.
Read Next:
<ul class="wp-block-list">
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
</ul>
Image: Shutterstock

65-Year-Old With $1.7 Million Nest Egg Hates Idea Of Spending In Retirement — Dave Ramsey Tells Him To Go On A Cruise And 'Practice' Having Fun

Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) has outperformed the market over the past 5 years by 27.14% on an annualized basis producing an average annual return of 41.27%. Currently, Cloudflare has a market capitalization of $54.60 billion. 
Buying $1000 In NET: If an investor had bought $1000 of NET stock 5 years ago, it would be worth $5,626.20 today based on a price of $157.55 for NET at the time of writing.
<h3>Cloudflare's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748039410_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Cloudflare 5 Years Ago Would Be Worth Today

In the last three months, 4 analysts have published ratings on Cracker Barrel Old (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Cracker Barrel Old, presenting an average target of $46.5, a high estimate of $55.00, and a low estimate of $39.00. Observing a 1.64% increase, the current average has risen from the previous average price target of $45.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1748037699_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Cracker Barrel Old is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Sell</td>
<td>$42.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$55.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Sell</td>
<td>$39.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Alton Stump</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$50.00</td>
<td>$55.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Cracker Barrel Old. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Cracker Barrel Old compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Cracker Barrel Old's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Cracker Barrel Old's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CBRL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cracker Barrel Old analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Cracker Barrel Old: A Closer Look</h2>
Cracker Barrel Old Country Store Inc operates hundreds of full-service restaurants throughout the United States. The restaurants of the company are open for breakfast, lunch, and dinner, with menus that offer home-style country food. The company generates maximum revenue from the Restaurants.
<h3>A Deep Dive into Cracker Barrel Old's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Cracker Barrel Old's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.5% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Cracker Barrel Old's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 2.34%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.93%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Cracker Barrel Old's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.02%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 2.45.
<h2>Analyst Ratings: What Are They?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

CBRL

Assessing Cracker Barrel Old: Insights From 4 Financial Analysts

Ratings for Eagle Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $249.38, with a high estimate of $280.00 and a low estimate of $237.00. Experiencing a 10.11% decline, the current average is now lower than the previous average price target of $277.43. 
<img src="https://www.benzinga.com/files/images/story/2025/1748037677_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Eagle Materials by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brent Thielman</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$245.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Trey Grooms</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$255.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$241.00</td>
<td>$242.00</td>
</tr>
<tr>
<td>Garik Shmois</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$237.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$280.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Garik Shmois</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$245.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Adrian Huerta</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$250.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Announces</td>
<td>Hold</td>
<td>$242.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eagle Materials. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Eagle Materials compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Eagle Materials's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Eagle Materials's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EXP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Eagle Materials analyst ratings.</a>
<h2>Unveiling the Story Behind Eagle Materials</h2>
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
<h3>Eagle Materials: A Financial Overview</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, Eagle Materials faced challenges, resulting in a decline of approximately -1.37% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Eagle Materials's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 14.14%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.5%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.11%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 0.88, caution is advised due to increased financial risk.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Eagle Materials In The Eyes Of 8 Experts

9 analysts have shared their evaluations of Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $88.33, a high estimate of $110.00, and a low estimate of $74.00. This current average represents a 19.38% decrease from the previous average price target of $109.56. 
<img src="https://www.benzinga.com/files/images/story/2025/1748037664_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A clear picture of Coherent's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$74.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Mark Miller</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$95.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$95.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$85.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$80.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$136.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$85.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Simon Leopold</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$91.00</td>
<td>$110.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Coherent. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Coherent compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Coherent's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Coherent's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/COHR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Coherent analyst ratings.</a>
<h2>Unveiling the Story Behind Coherent</h2>
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
<h3>Coherent: Financial Performance Dissected</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Coherent's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 23.91%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.13%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -0.32%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.12%, the company showcases effective utilization of assets.
Debt Management: Coherent's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.74, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COHR

Breaking Down Coherent: 9 Analysts Share Their Views

Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) underwent analysis by 13 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">12</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $53.15, with a high estimate of $62.00 and a low estimate of $47.00. This current average represents a 5.6% decrease from the previous average price target of $56.30. 
<img src="https://www.benzinga.com/files/images/story/2025/1748037649_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of Viper Energy by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kalei Akamine</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$50.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$61.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>William Janela</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$54.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Stephen Richardson</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$49.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$47.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$62.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Tim Rezvan</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$49.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>William Janela</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$56.00</td>
<td>-</td>
</tr>
<tr>
<td>Hanwen Chang</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$51.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$56.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Viper Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Viper Energy compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Viper Energy's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Viper Energy's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VNOM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Viper Energy analyst ratings.</a>
<h2>Delving into Viper Energy's Background</h2>
Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.
<h3>Viper Energy: Financial Performance Dissected</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Viper Energy's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 19.51%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Viper Energy's net margin excels beyond industry benchmarks, reaching 30.61%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Viper Energy's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.44%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.33%, the company showcases effective utilization of assets.
Debt Management: Viper Energy's debt-to-equity ratio is below the industry average at 0.31, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VNOM

Viper Energy Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)

Legal

Press Releases

Biodexa Announces Allowance of U.S. Patent Covering  Oral Rapamycin Nanoparticle Preparations ("eRapa") and Use

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP

Health Care

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP

With Fast Track Designation in Hand, a Successful Protocol Discussion with FDA, and CROs in Place, Biodexa is on Track to Initiate its Funded Phase 3 Trial in FAP Next Quarter

Preliminary Results for the Year Ended 31 December 2024

Notice of General Meeting

Result of General Meeting

Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP

Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational  eRapa Phase 3 Program in FAP  Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M

Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company")  Notice of General Meeting

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Azitra

Bone Biologics

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Galecto

GRI Bio

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Palisade Bio

Protagenic Therapeutics, Inc. - Common Stock

Protagenic Therapeutics

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Tharimmune

Theriva Biologics

VivoSim Labs

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Ladenburg Thalmann

Screenshot 2025-03-18 at 8.36.36 PM

Biotech

General

Fast Track Designation Secured, Successful Protocol Discussion With FDA And CROs Confirmed, Biodexa On Track To Initiate Funded Phase 3 FAP Trial Next Quarter

Untitled design - 2025-02-11T232646.924

Following Positive Phase 2 Results And Orphan Drug Designation, Biodexa&#39;s FAP Drug Receives FDA Fast Track Status

Image

Gaining Momentum, Biodexa Is Advancing Two Recent Acquisitions Through The Clinic

Untitled design - 2024-10-16T235234.675

Biodexa&#39;s MX-110 Continues To Show Promise In Recurrent Glioblastoma (rGBM), The Deadliest Brain Cancer

Screenshot 2024-07-10 at 9.15.35 PM

Biodexa Announces Additional Positive Results Of Phase 2 Trial Of eRapa In Treatment Of Precancerous Polyps In The GI Tract – Now 12-Month Data

Screenshot 2024-06-03 at 5.21.04 PM

Promising Phase 2 Results For Biodexa&#39;s eRapa™ Indicates Hope For FAP Patients Who Otherwise Have A 100% Lifetime Risk Of Colorectal Cancer

Screenshot 2024-05-08 at 7.48.00 PM

Biodexa Looks To Prevent Or Delay The Worst Outcomes For Adolescents And Young Adults With Devastating Precancerous Condition

Untitled design - 2024-03-28T172702.605

Biodexa&#39;s MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers

Redington 2_29

PowerShares Dynamic Financial Sector Portfolio

Comments

Biodexa Pharmaceuticals

Noticias

Últimas noticias sobre Biodexa Pharmaceuticals (NASDAQ:BDRX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL